Nanoparticle-Based Drug Delivery in Cancer Treatment
Nanoparticle-Based Drug Delivery in Cancer Treatment
YOU SAVE £17.20
- Condition: Brand new
- UK Delivery times: Usually arrives within 2 - 3 working days
- UK Shipping: Fee starts at £2.39. Subject to product weight & dimension
- More about Nanoparticle-Based Drug Delivery in Cancer Treatment
Nanoparticle-Based Drug Delivery in Cancer Treatment explores the use of nanoparticles as targets and drug delivery routes to enhance therapeutic efficacy in cancer. It reviews recent advances in nanoparticle-mediated siRNA delivery systems and their application in clinical trials, highlights promising systems for clinical application, and surveys progress in nanoparticle-based nanomedicine.
Format: Hardback
Length: 534 pages
Publication date: 28 February 2022
Publisher: Taylor & Francis Ltd
The strategic selection of nanoparticles as both targets and drug delivery routes plays a pivotal role in enhancing the therapeutic efficacy of cancer treatment. In Nanoparticle-Based Drug Delivery in Cancer Treatment, a comprehensive exploration of the latest nanotechnological advancements is presented, shedding light on the development of interfering RNA-based nanoparticles, delivery vehicles, and the validation of therapeutic RNAi-molecular target interactions. The book delves into the outcomes of clinical and preclinical trials, providing valuable insights into the effectiveness of nanoparticle-based therapies in combating cancer. Furthermore, it offers strategies for the universal construction of hybrid organic–inorganic nanomaterials, which have broad applications in the biomedical field.
Key Features:
1. Reviews recent advancements in nanoparticle-mediated siRNA delivery systems and their clinical applications in cancer therapy.
2. Focuses on material platforms that facilitate the formation of nanoparticles and the regulation of gene silencing, both locally and controlled.
3. Emphasizes the most promising systems for clinical translation, surveying progress in nanoparticle-based nanomedicine for cancer treatment.
4. Describes the most advanced nonviral nanocarriers for the efficient delivery of oligonucleotides to malignant blood cancer cells.
This book serves as a valuable resource for researchers, professors, and students engaged in the fields of drug delivery, gene carriers, cancer therapy, nanotechnology, and nanomaterials. It offers a comprehensive and up-to-date account of the latest developments in nanoparticle-based drug delivery, providing valuable insights into the potential of this innovative approach to cancer treatment.
Dimension: 280 x 210 (mm)
ISBN-13: 9781032135205
This item can be found in:
UK and International shipping information
UK and International shipping information
UK Delivery and returns information:
- Delivery within 2 - 3 days when ordering in the UK.
- Shipping fee for UK customers from £2.39. Fully tracked shipping service available.
- Returns policy: Return within 30 days of receipt for full refund.
International deliveries:
Shulph Ink now ships to Australia, Belgium, Canada, France, Germany, Ireland, Italy, India, Luxembourg Saudi Arabia, Singapore, Spain, Netherlands, New Zealand, United Arab Emirates, United States of America.
- Delivery times: within 5 - 10 days for international orders.
- Shipping fee: charges vary for overseas orders. Only tracked services are available for most international orders. Some countries have untracked shipping options.
- Customs charges: If ordering to addresses outside the United Kingdom, you may or may not incur additional customs and duties fees during local delivery.